1-10 of 10
Alberto Ocaña
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 509: The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancer

Gemma Texido, Fabio Gasparri, Antonella Ciavolella, Laura Gianellini, Anders E. Pedersen, Alberto Ocaña, Riccardo Colombo, Domenico Roberti, Lisa Mahnke, Claudia Perrera
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 509.
https://doi.org/10.1158/1538-7445.AM2024-509
Published: 22 March 2024
View articletitled, Abstract 509: The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancer
Journal Articles

Abstract P2-01-18: Orthogonal assessment of PIK3CA and ESR1 mutation detection in longitudinal cfDNA samples from endocrine-resistant HR+/HER2- advanced breast cancer patients using dPCR and NGS-based SafeSEQ technology

Jesus Fuentes Antras, Vanesa García-Barberán, Fernando Moreno, Hillary Sloane, Igor López-Cade, Alicia De Luna, Alejandro Pascual, Carmen Ramirez-Ruda, Victor Lorca, Paloma Flores, Pedro Perez-Segura, Alberto Ocaña, Jennifer Preston, Hannah Quinn, Frederick Jones, Jose Angel Garcia-Saenz
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-01-18.
https://doi.org/10.1158/1538-7445.SABCS21-P2-01-18
Published: 15 February 2022
View articletitled, Abstract P2-01-18: Orthogonal assessment of PIK3CA and ESR1 mutation detection in longitudinal cfDNA samples from endocrine-resistant HR+/HER2- advanced breast cancer patients using dPCR and NGS-based SafeSEQ technology
Journal Articles

Abstract P3-05-06: Genome-wide DNA methylation analysis identifies novel biomarkers associated with risk of relapse beyond oncotype DX recurrence-score risk assessment within HR+/HER2- early-stage breast cancer patients

Jesus Fuentes-Antrás, Vanesa García-Barberán, Nicolas Costa-Fraga, Fernando Moreno, Aida Bao-Caamano, Aitor Rodríguez-Casanova, Alfonso López de Sá, Alicia De Luna, Igor Lopez-Cade, Carmen Ramirez-Ruda, Alejando Pascual, Pedro Perez-Segura, Balázs Győrffy, Alberto Ocaña, Angel Diaz-Lagares, Jose Angel Garcia-Saenz
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P3-05-06.
https://doi.org/10.1158/1538-7445.SABCS21-P3-05-06
Published: 15 February 2022
View articletitled, Abstract P3-05-06: Genome-wide DNA methylation analysis identifies novel biomarkers associated with risk of relapse beyond oncotype DX recurrence-score risk assessment within HR+/HER2- early-stage breast cancer patients
Journal Articles

Abstract P4-10-11: PIK3CA status as a predictor of benefit from drugs targeting the PI3K/AKT/mTOR pathway: A meta-analysis of randomized trials

Fahad A Almugbel, Ramy Saleh, Alberto Ocana, Atanasio Pandiella, Eitan Amir
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-10-11.
https://doi.org/10.1158/1538-7445.SABCS19-P4-10-11
Published: 15 February 2020
View articletitled, Abstract P4-10-11: PIK3CA status as a predictor of benefit from drugs targeting the PI3K/AKT/mTOR pathway: A meta-analysis of randomized trials
Journal Articles

Abstract 1608: Pharmacologic screening identifies synthetic lethality interactions with Chk1 inhibitors in basal-like breast and ovarian cancer

Eva M. Galan-Moya, Ana Alcaraz-Sanabria, Cristina Nieto-Jimenez, Veronica Corrales-Sanchez, Miriam Nuncia-Cantarero, Juan C. Montero, Atanasio Pandiella, Alberto Ocaña
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1608.
https://doi.org/10.1158/1538-7445.AM2018-1608
Published: 01 July 2018
View articletitled, Abstract 1608: Pharmacologic screening identifies synthetic lethality interactions with Chk1 inhibitors in basal-like breast and ovarian cancer
Journal Articles

Resistance to Antibody–Drug Conjugates

Sara García-Alonso, Alberto Ocaña, Atanasio Pandiella
Journal: Cancer Research
Cancer Res (2018) 78 (9): 2159–2165.
https://doi.org/10.1158/0008-5472.CAN-17-3671
Published: 30 April 2018
View articletitled, Resistance to Antibody–Drug Conjugates
Open the PDF for Resistance to Antibody–Drug Conjugates in another window
Journal Articles

Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity

Carla Ríos-Luci, Sara García-Alonso, Elena Díaz-Rodríguez, Mercedes Nadal-Serrano, Joaquín Arribas, Alberto Ocaña, Atanasio Pandiella
Journal: Cancer Research
Cancer Res (2017) 77 (17): 4639–4651.
https://doi.org/10.1158/0008-5472.CAN-16-3127
Published: 31 August 2017
View articletitled, Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity
Open the PDF for Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity in another window
Includes: Multimedia, Supplementary data
Journal Articles

Toward Value-Based Pricing to Boost Cancer Research and Innovation

Alberto Ocana, Eitan Amir, Ian F. Tannock
Journal: Cancer Research
Cancer Res (2016) 76 (11): 3127–3129.
https://doi.org/10.1158/0008-5472.CAN-15-3179
Published: 31 May 2016
View articletitled, Toward Value-Based Pricing to Boost Cancer Research and Innovation
Open the PDF for Toward Value-Based Pricing to Boost Cancer Research and Innovation in another window
Journal Articles

Abstract OT1-1-06: A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study)

Miguel Martin, Manuel Ruiz-Borrego, José M Trigo, Silvia Antolin, Jose A Garcia-Saenz, Andres Hernando, Alberto Ocaña, Federico Rojo, Sara Lopez-Tarruella, Jesus Corral, Nuria Ribelles, Lourdes Calvo, Fernando Moreno, Rosalia Caballero, Eva Carrasco
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): OT1-1-06.
https://doi.org/10.1158/1538-7445.SABCS14-OT1-1-06
Published: 01 May 2015
View articletitled, Abstract OT1-1-06: A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study)
Journal Articles

Abstract 3630: In vitro and in vivo antitumor activity of multi-tyrosine Kinase inhibitors in neuroblastoma

Raul Calero, Rosario Serrano, Laura Avendaño, Enrique Poblet, Alberto Ocana
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3630.
https://doi.org/10.1158/1538-7445.AM10-3630
Published: 15 April 2010
View articletitled, Abstract 3630: In vitro and in vivo antitumor activity of multi-tyrosine Kinase inhibitors in neuroblastoma